Business
Sotera Health to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
CLEVELAND, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization
About this update from Sotera Health Company
[{"type":"text","content":"CLEVELAND, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 7:30 am ET. A link to the live and archived webcast may be accessed on the Sotera Health website under the Investor Relations section: https://investors.soterahealth.com/events-and-presentations. About Sotera Health: Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®. INVESTOR RELATIONS CONTACTS: Sally J. Curley, IRCJenny KobinCurley Global IR, LLCIR Advisory [email protected]@soterahealth.com MEDIA CONTACT: Kristin GibbsChief Marketing Officer, Sotera [email protected] Source: Sotera Health Company \nSource: Sotera Health Services, LLC","length":3557,"tagName":"div"}]